A recent Phase II clinical trial published in the journal CANCER suggests that exercise and low-dose ibuprofen can significantly reduce cognitive impairments experienced by cancer patients undergoing chemotherapy. The study, led by Michelle C. Janelsins from the University of Rochester, involved 86 cancer patients who reported cognitive issues. Participants were randomized into four groups for six weeks, receiving either home-based exercise combined with ibuprofen, exercise with a placebo, ibuprofen alone, or a placebo. Results indicated that the exercise groups showed improved attention and reduced cognitive slips reported by friends and family. Exercise, in particular, demonstrated a more pronounced effect on cognitive function compared to ibuprofen alone. The findings suggest that both interventions may help mitigate 'chemo brain,' a condition affecting up to 80% of chemotherapy patients, characterized by memory and concentration difficulties. While further Phase 3 trials are needed to confirm these results, the study highlights the potential benefits of integrating exercise and ibuprofen into treatment plans for cancer-related cognitive impairment.